Image

Vaccination against human papillomavirus (HPV) is one of the most effective tools for preventing cervical cancer in women and other HPV-associated diseases in people of all genders. Yet many people worldwide remain reluctant to take the vaccine.

A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.

Cochrane, the Campbell Collaboration, JBI, and the Collaboration for Environmental Evidence have published a joint position statement on the responsible use of artificial intelligence (AI) in evidence synthesis.

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.

We continue to lead the field in trustworthiness and transparency by evolving our practices to address the most pressing challenges in research integrity and publishing ethics, and to respond to rapid advances in technology. Here is a wrap up of recent developments in these areas.

When someone gets injured or collapses in a public place, the first person to help is rarely a medical professional. First aid training for laypeople is promoted around the world, but is it effective? Researchers from Cochrane First Aid and the Centre for Evidence-Based Practice (CEBaP) have produced a Cochrane review providing some answers. Discover how the review came about, what it found and what it could mean in practice.

Immediate skin-to-skin contact between newborns and their mothers offers a better start in life, improving a number of key health metrics, according to a newly-updated Cochrane review.

Read the 14th Cochrane Methods report, providing an overview of the key methodological activities in Cochrane for 2024–2025.

This year, World Evidence-based Healthcare Day is focusing on exchanging information and ideas in creative and collaborative ways.

Cochrane is seeking a public collaborator to help shape a global human papillomavirus (HPV) vaccination campaign to support families in making informed decisions about the HPV vaccine.

Cochrane joined global health leaders at the World Health Summit’s Academic Alliance session on confronting disinformation in the global anti-vaccine discourse. Together, they discussed how disinformation continues to undermine vaccine confidence and threaten public health worldwide.

Join us behind the scenes for reflections, best practices and impact stories from author teams, Geographic Groups, and others involving patients and the public in Cochrane activities. This month we meet Dr. Robby Nieuwlaat from Cochrane Canada.

We are excited to announce the launch of a new application round for Cochrane Thematic Groups, with a dedicated focus on infectious diseases.

October 11th marks International Day of the Girl Child, a day that calls for policies that protect girls’ rights and enable their leadership. Pakistan recently introduced the human papilloma virus (HPV) vaccine for girls, aiming for a 90% vaccination rate. Dr Muhammad Tayyab Qureshi, from Cochrane Pakistan, reflects on the vaccine campaign so far, and the value of investing in girl’s futures.

The World Health Organization has launched the Global Clinical Trials Forum, a global, multi-stakeholder network to strengthen clinical trial environments and infrastructure at national, regional and global levels. Cochrane is pleased to be a member of this initiative.

In this video, Karla shares her vision for creating an evidence ecosystem that is fast, fair and fit for the future, with collaboration at the heart of this. Watch to find out more.

Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, a new Cochrane review has found.

Cochrane’s Governing Board is pleased to announce the appointment of Dr Karla Soares-Weiser as the organization’s new Chief Executive Officer.

Our Methods Groups provide policy advice and focus on developing the methods used to produce Cochrane reviews. Over the past year they’ve been working hard on activities from writing papers on responsible AI use to identifying research priorities.